Mitchell Mcleod Pugh & Williams Inc. Sells 390 Shares of Elevance Health, Inc. (NYSE:ELV)

Mitchell Mcleod Pugh & Williams Inc. trimmed its position in shares of Elevance Health, Inc. (NYSE:ELV) by 10.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,325 shares of the company’s stock after selling 390 shares during the quarter. Mitchell Mcleod Pugh & Williams Inc.’s holdings in Elevance Health were worth $1,227,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of ELV. Raelipskie Partnership purchased a new position in Elevance Health in the third quarter worth about $26,000. PSI Advisors LLC purchased a new position in shares of Elevance Health in the third quarter worth approximately $27,000. Eastern Bank bought a new stake in Elevance Health during the third quarter valued at approximately $31,000. Dunhill Financial LLC increased its holdings in Elevance Health by 57.8% during the third quarter. Dunhill Financial LLC now owns 71 shares of the company’s stock valued at $37,000 after buying an additional 26 shares during the last quarter. Finally, Peterson Financial Group Inc. bought a new position in Elevance Health in the third quarter worth approximately $44,000. 89.24% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

ELV has been the subject of several analyst reports. Barclays reduced their price objective on Elevance Health from $622.00 to $501.00 and set an “overweight” rating for the company in a research note on Tuesday, October 22nd. StockNews.com raised Elevance Health from a “hold” rating to a “buy” rating in a research note on Friday. Cantor Fitzgerald cut their price objective on Elevance Health from $600.00 to $485.00 and set an “overweight” rating for the company in a research note on Friday, October 18th. TD Cowen decreased their target price on shares of Elevance Health from $589.00 to $484.00 and set a “buy” rating on the stock in a research note on Monday, October 21st. Finally, Truist Financial dropped their price target on shares of Elevance Health from $520.00 to $480.00 and set a “buy” rating for the company in a research report on Monday, January 6th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Elevance Health presently has a consensus rating of “Moderate Buy” and an average price target of $536.53.

Elevance Health Trading Down 0.3 %

Shares of ELV stock opened at $384.26 on Monday. The company has a current ratio of 1.50, a quick ratio of 1.50 and a debt-to-equity ratio of 0.56. The stock has a market capitalization of $89.12 billion, a price-to-earnings ratio of 14.01, a price-to-earnings-growth ratio of 1.08 and a beta of 0.84. Elevance Health, Inc. has a 12-month low of $362.21 and a 12-month high of $567.26. The stock’s 50-day moving average price is $388.02 and its 200-day moving average price is $466.63.

Elevance Health (NYSE:ELV) last released its quarterly earnings data on Thursday, October 17th. The company reported $8.37 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $9.66 by ($1.29). The firm had revenue of $44.72 billion during the quarter, compared to the consensus estimate of $43.47 billion. Elevance Health had a return on equity of 19.56% and a net margin of 3.68%. The business’s revenue was up 5.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $8.99 EPS. Equities research analysts predict that Elevance Health, Inc. will post 32.96 EPS for the current fiscal year.

About Elevance Health

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.